Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Diagnosis and Treatment of Palmar Desquamation with Pruritus

Differential Diagnosis

  • The American Heart Association suggests that the absence of fever, acute erythema of palms/soles, and the temporal pattern (desquamation in Kawasaki disease occurs 2-3 weeks post-fever) can help rule out Kawasaki disease 1, 2

Treatment Plan

  • The American Academy of Dermatology recommends continuing and optimizing emollient therapy with urea and paraffin, applying at least once a day to the entire body, with more frequent applications to affected areas 3, 5, 6
  • The National Institute of Health suggests adding moderate to high potency topical corticosteroids, such as prednicarbato cream 0.02% or betamethasone valerate 0.1% ointment, to be applied twice a day for 2 weeks 3, 5
  • The European Academy of Dermatology and Venereology recommends using antipruritic topical therapy, such as lotions containing urea or polidocanol, to relieve pruritus 5, 6

Preventive Measures

  • The American Academy of Dermatology advises avoiding hot showers, excessive use of soap, and friction/trauma, and applying emollients to cuticles and periungual tissues daily 3, 6

Reevaluation and Escalation of Treatment

  • The American Academy of Dermatology recommends reevaluating the patient after 2 weeks of optimized topical treatment, and considering referral to dermatology if there is no improvement or worsening of symptoms 3, 5
  • The National Institute of Health suggests considering second-line options, such as antiepileptic agents (pregabalin 25-150 mg daily or gabapentin 900-3600 mg daily) for refractory pruritus, under dermatological supervision 5, 6

Important Warnings

  • The American Academy of Dermatology warns against discontinuing current therapy (urea with paraffin) as it shows good response, and avoiding prolonged use of high-potency topical corticosteroids without supervision to prevent cuticular atrophy 3, 5
  • The Centers for Disease Control and Prevention recommends monitoring for secondary overinfection (impetiginization by staphylococci or streptococci) that would require antibiotic treatment 3